Purixan®

This slideshow reviews drug information for PURIXAN® (mercaptopurine [6-MP] oral suspension), indicated for acute lymphoblastic leukemia.

Topical Gel for Preventive Breast Cancer Therapy

A topical gel containing an active metabolite of tamoxifen suppressed cell proliferation equally as well as the oral form.

Obesity and Cancer Care

ASCO recommendation tasks oncologists with assisting obese patients with cancer in finding appropriate resources for weight management.

Supreme Court Ruling Affects Cancer Prevention

SCOTUS decision in Hobby Lobby case reaches beyond contraception.

Everolimus in Hepatocellular Carcinoma

Researchers continue to search for a molecular pathway or biomarker to improve treatment options for patients with sorafenib-refractory HCC.

Novel Combination for Refractory Metastatic CRC

Results of the RECOURSE trial may make the combination agent a new standard of care in advanced disease.

Collaborative Trials to Speed Drug Development

Lung-MAP and the National Lung Matrix Trial aim to deliver precision-based treatment to patients with lung cancer by using a streamlined trial design

Featured Videos

Viewpoints & Feature Articles

Circumcision May Reduce Prostate Cancer Risk

Circumcision May Reduce Prostate Cancer Risk

The evidence continues to grow that circumcision may help lower a man's overall risk for prostate cancer.

Topical Gel May Be as Effective as Oral Tamoxifen in DCIS

Topical Gel May Be as Effective as Oral Tamoxifen in DCIS

A topical gel containing an active metabolite of tamoxifen suppressed cell proliferation equally as well as the oral form.

Oncologists Asked to Play Greater Role in Helping Obese Patients With Cancer

Oncologists Asked to Play Greater Role in Helping Obese Patients With Cancer

ASCO recommendation tasks oncologists with assisting obese patients with cancer in finding appropriate resources for weight management.

Helping Patients With Cancer Avoid Financial Toxicity

Helping Patients With Cancer Avoid Financial Toxicity

Cancer care costs are becoming a significant problem; however, a new tool may help oncologists assess how patients will be affected by treatment expenses.


Editorial Advisory Board

 

Barbara Ann Burtness, MD

Steven Cohen, MD

E. David Crawford, MD

Don S. Dizon, MD, FACP

Jeffrey M. Farma, MD

Edith A. Perez, MD

Neal D. Shore, MD, FACS

Mark A. Socinski, MD

Mario Sznol, MD

Click here for complete profiles


From Oncology Nurse Advisor

CTA Community Poll

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs